期刊文献+

62例肝性脑病预后危险因素分析 被引量:4

下载PDF
导出
摘要 目的探讨肝性脑病(HE)预后的危险因素。方法对62例肝性脑病患者的临床资料进行回顾性分析,探讨其发生诱因、复发、预后相关危险因素。结果 62例肝性脑病患者的发生及预后与消化道出血、感染、电解质紊乱、高蛋白饮食、镇静药物、利尿剂不规范使用等方面有密切关系。结论肝性脑病发生的诱因及预后和多种因素相关,治疗上尽可能去除诱因,以降低HE的发生率及死亡率。
作者 杨俊 乔永灵
出处 《中国实用医药》 2015年第12期84-85,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献18

  • 1Tarek I. Hassanein,Robin C. Hilsabeck,William Perry.Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)[J]. Digestive Diseases and Sciences . 2008 (2)
  • 2Marsha Y. Morgan,A. Blei,K. Grüngreiff,R. Jalan,G. Kircheis,G. Marchesini,O. Riggio,Karin Weissenborn.The treatment of hepatic encephalopathy[J]. Metabolic Brain Disease . 2007 (3-4)
  • 3Plauth M,Cabre E,Riggio O,et al.ESPEN Guidelines on Enteral Nutrition:Liver disease. Clinical Nutrition . 2006
  • 4Als-Nielsen B,Gluud LL,Gluud C.Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database of Systematic Reviews . 2004
  • 5Poo JL,Gongora J,Sanchez-Avila F,et al.Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.Results of a randomized,lactulose-controlled study. Annals of Hematology . 2006
  • 6Mas A.Rodes J,Sunyer L.et al.Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy:results of a randomized,double-blind,double dummy,controlled clinical trial. Journal of Hepatology . 2003
  • 7Jiang Q,Jiang XH,Zheng MH,et al.Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy:a meta-analysis. European Journal of Gastroenterology and Hepatology . 2008
  • 8Ahmad I,Khan AA,Alam A,et al.L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J Coll Physicians Surg Pak . 2008
  • 9Romero-Gomez M,Cordoba J,Jover R,et al.Value of the critical flicker frequency in patients with minimal hepatic encephalop-athy. Hepatology . 2007
  • 10Prasad S,Dhiman RK,Duseja A,Chawla YK,Sharma A,Agarwal R.Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology . 2007

共引文献259

同被引文献30

  • 1邢卉春.肝性脑病诊断治疗专家共识[J].中国肝脏病杂志(电子版),2009,1(2):46-55. 被引量:39
  • 2保志军,邱德凯,马雄,张赣生,范竹萍,黄一沁,于晓峰,曾民德.轻微肝性脑病的生命质量评价[J].中华肝脏病杂志,2007,15(6):412-416. 被引量:10
  • 3Khanna S,Gopalan S.Role of branched-chain amino acids in liver disease:the evidence for and against[J].Curr Opin Clin Nutr Metab Care,2010,10:297-303.
  • 4Ferenci P,Lockwood A,Mullen K,et al.Hepatic encephalopathy definition,nomenclature,diagnosis,and quantification:final report of the Working Party at the 11th World Congresses of Gastroenterology Vienna,1998[J].Hepatology,2002,35:716-721.
  • 5Mesejo A,Juan M,Serrano A.Liver cirrhosis and encephalopathy:clinical and metabolic consequences and nutritional support[J].Nutr Hosp,2008,23(2):8-18.
  • 6Cordoba J,Mínguez B.Hepatic encephalopathy[J].Semin Liver Dis,2010,28:70-80.
  • 7Romeroweg M,Boza F,Garcia-Valdecasas MS,et al.Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy[J].Am J Gastroenterol,2009,96(9):2718.
  • 8Poordad FF.Review article:the burden of hepatic encephalopathy[J].Aliment Pharmacol Ther,2007,25(Suppl 1):3-9.
  • 9玉艳红,江建宁,吴继周,庞辉.肝性脑病患者预后影响因素的Logistic回归分析[J].中华传染病杂志,2009,27(5):305-307. 被引量:7
  • 10占国清,谭华炳,朱琳,李儒贵,张薇薇.86例肝性脑病预后影响因素的回顾分析[J].临床消化病杂志,2010,22(1):44-45. 被引量:5

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部